Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma

BACKGROUND: Classical patient and tumour characteristics are the benchmark of personalised breast cancer (BC) management. Recent evidence has demonstrated that immune and molecular profiling of BC may also play an important role. Despite evidence of differences between invasive ductal (IDC) and lobu...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Engels, C C, Fontein, D B Y, Kuppen, P J K, de Kruijf, E M, Smit, V T H B M, Nortier, J W R, Liefers, G J, van de Velde, C J H, Bastiaannet, E
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2014
Teme:
Molecular Diagnostics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119991/
https://ncbi.nlm.nih.gov/pubmed/24937677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.338
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items